Study: Cannabinoids May Treat Chronic Inflammation

Cannabinoids may provide a treatment option for chronic inflammation, according to a new study published in the FASEB Journal, and published online by the U.S. National Institute of Health.

flower-power-2“Cannabinoids apparently act on inflammation through mechanisms different from those of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs)”, states the study’s abstract. “As a class, the cannabinoids are generally free from the adverse effects associated with NSAIDs. Their clinical development thus provides a new approach to treatment of diseases characterized by acute and chronic inflammation and fibrosis.”

For the study, a “concise survey of the anti-inflammatory actions of the phytocannabinoids Δ9-tetrahydrocannabinol (THC), cannabidiol, cannabichromene, and cannabinol” is presented.

According to researchers; “The review concludes with a presentation of a possible mechanism for the anti-inflammatory and antifibrotic actions of these substances. Thus, several cannabinoids may be considered candidates for development as anti-inflammatory and antifibrotic agents.”

Of special interest, the study states, “is their possible use for treatment of chronic inflammation, a major unmet medical need.”

The full study, conducted by researchers at the University of Massachusetts Medical School, can be found by clicking here.

Leave a Reply

Your email address will not be published.